|
1
|
Ho Y and Dehm SM: Androgen receptor
rearrangement and splicing variants in resistance to endocrine
therapies in prostate cancer. Endocrinology. 158:1533–1542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pedraza-Arevalo S, Hormaechea-Agulla D,
Gomez-Gomez E, Requena MJ, Selth LA, Gahete MD, Castaño JP and
Luque RM: Somatostatin receptor subtype 1 as a potential diagnostic
marker and therapeutic target in prostate cancer. Prostate.
77:1499–1511. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Culig Z: Androgen receptor coactivators in
regulation of growth and differentiation in prostate cancer. J Cell
Physiol. 231:270–274. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Luo C and Zhang H: The role of
proinflammatory pathways in the pathogenesis of colitis-associated
colorectal cancer. Mediators Inflamm. 2017:51260482017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Debes JD, Schmidt LJ, Huang H and Tindall
DJ: p300 mediates androgen-independent transactivation of the
androgen receptor by interleukin 6. Cancer Res. 62:5632–5636.
2002.PubMed/NCBI
|
|
6
|
Han IH, Kim JH, Kim SS, Ahn MH and Ryu JS:
Signalling pathways associated with IL-6 production and
epithelial-mesenchymal transition induction in prostate epithelial
cells stimulated with Trichomonas vaginalis. Parasite Immunol.
38:678–687. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xie S, Lin HK, Ni J, Yang L, Wang L, di
Sant'Agnese PA and Chang C: Regulation of interleukin-6-mediated
PI3K activation and neuroendocrine differentiation by androgen
signaling in prostate cancer LNCaP cells. Prostate. 60:61–67. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Wang L, Lin HK, Kan PY, Xie S,
Tsai MY, Wang PH, Chen YT and Chang C: Interleukin-6 differentially
regulates androgen receptor transactivation via PI3K-Akt, STAT3,
and MAPK, three distinct signal pathways in prostate cancer cells.
Biochem Biophys Res Commun. 305:462–469. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu N, Zheng JX, Zhuang YS, Zhou ZK, Zhao
JH and Yang L: Anti-inflammatory effects of Schisandrin B on
LPS-stimulated BV2 microglia via activating PPAR-γ. Inflammation.
40:1006–1011. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Checker R, Patwardhan RS, Sharma D, Menon
J, Thoh M, Bhilwade HN, Konishi T and Sandur SK: Schisandrin B
exhibits anti-inflammatory activity through modulation of the
redox-sensitive transcription factors Nrf2 and NF-κB. Free Radic
Biol Med. 53:1421–1430. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang X, Wang S, Mu Y and Zheng Y:
Schisandrin B inhibits cell proliferation and induces apoptosis in
human cholangiocarcinoma cells. Oncol Rep. 36:1799–1806. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu XN, Zhang CY, Jin XD, Li YZ, Zheng XZ
and Li L: Inhibitory effect of Schisandrin B on gastric cancer
cells in vitro. World J Gastroenterol. 13:6506–6511. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang Y, Zhang Q, Bao J, Du C, Wang J,
Tong Q and Liu C: Schisandrin B suppresses glioma cell metastasis
mediated by inhibition of mTOR/MMP-9 signal pathway. Biomed
Pharmacother. 74:77–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xin DQ, Hu ZM, Huo HJ, Yang XJ, Han D,
Xing WH, Zhao Y and Qiu QH: Schisandrin B attenuates the
inflammatory response, oxidative stress and apoptosis induced by
traumatic spinal cord injury via inhibition of p53 signaling in
adult rats. Mol Med Rep. 16:533–538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Inoue H, Waiwut P, Saiki I, Shimada Y and
Sakurai H: Gomisin N enhances TRAIL-induced apoptosis via reactive
oxygen species-mediated up-regulation of death receptors 4 and 5.
Int J Oncol. 40:1058–1065. 2012.PubMed/NCBI
|
|
16
|
Nasser MI, Masood M, Wei W and Li X, Zhou
Y, Liu B, Li J and Li X: Cordycepin induces apoptosis in SGC7901
cells through mitochondrial extrinsic phosphorylation of PI3K/Akt
by generating ROS. Int J Oncol. 50:911–919. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mao J, Hu X, Pang P, Zhou B, Li D and Shan
H: miR-30e acts as a tumor suppressor in hepatocellular carcinoma
partly via JAK1/STAT3 pathway. Oncol Rep. 38:393–401. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim KY, Park KI, Kim SH, Yu SN, Park SG,
Kim YW, Seo YK, Ma JY and Ahn SC: Inhibition of autophagy promotes
salinomycin-induced apoptosis via reactive oxygen species-mediated
PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human
prostate cancer cells. Int J Mol Sci. 18:E10882017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Changou CA, Chen YR, Xing L, Yen Y, Chuang
FY, Cheng RH, Bold RJ, Ann DK and Kung HJ: Arginine
starvation-associated atypical cellular death involves
mitochondrial dysfunction, nuclear DNA leakage, and chromatin
autophagy. Proc Natl Acad Sci USA. 111:14147–14152. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dilly AK, Ekambaram P, Guo Y, Cai Y,
Tucker SC, Fridman R, Kandouz M and Honn KV: Platelet-type
12-lipoxygenase induces MMP9 expression and cellular invasion via
activation of PI3K/Akt/NF-κB. Int J Cancer. 133:1784–1791. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He Y, Huang H, Farischon C, Li D, Du Z,
Zhang K, Zheng X and Goodin S: Combined effects of atorvastatin and
aspirin on growth and apoptosis in human prostate cancer cells.
Oncol Rep. 37:953–960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abedinpour P, Baron VT, Chrastina A,
Rondeau G, Pelayo J, Welsh J and Borgström P: Plumbagin improves
the efficacy of androgen deprivation therapy in prostate cancer: A
pre-clinical study. Prostate. 77:1550–1562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Culig Z and Puhr M: Interleukin-6: A
multifunctional targetable cytokine in human prostate cancer. Mol
Cell Endocrinol. 360:52–58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang WL, Yeh HH, Lin CC, Lai WW, Chang
JY, Chang WT and Su WC: Signal transducer and activator of
transcription 3 activation up-regulates interleukin-6 autocrine
production: A biochemical and genetic study of established cancer
cell lines and clinical isolated human cancer cells. Mol Cancer.
9:3092010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Zhu W, Tao J, Xin P, Liu M, Li J and
Wei M: Fasudil protects the heart against ischemia-reperfusion
injury by attenuating endoplasmic reticulum stress and modulating
SERCA activity: The differential role for PI3K/Akt and JAK2/STAT3
signaling pathways. PLoS One. 7:e481152012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shanmugam MK, Rajendran P, Li F, Nema T,
Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Ho PC, et al:
Ursolic acid inhibits multiple cell survival pathways leading to
suppression of growth of prostate cancer xenograft in nude mice. J
Mol Med. 89:713–727. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma M, Ma Y, Zhang GJ, Liao R, Jiang XF,
Yan XX, Bie FJ, Li XB and Lv YH: Eugenol alleviated breast
precancerous lesions through HER2/PI3K-AKT pathway-induced cell
apoptosis and S-phase arrest. Oncotarget. 8:56296–56310.
2017.PubMed/NCBI
|
|
29
|
Cho SH, Park MH, Lee HP, Back MK, Sung HC,
Chang HW, Kim JH, Jeong HS, Han SB and Hong JT:
(E)-2,4-Bis(p-hydroxyphenyl)-2-butenal enhanced TRAIL-induced
apoptosis in ovarian cancer cells through downregulation of
NF-κB/STAT3 pathway. Arch Pharm Res. 37:652–661. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Selvaraj N, Budka JA, Ferris MW, Jerde TJ
and Hollenhorst PC: Prostate cancer ETS rearrangements switch a
cell migration gene expression program from RAS/ERK to PI3K/AKT
regulation. Mol Cancer. 13:612014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chae JK, Subedi L, Jeong M, Park YU, Kim
CY, Kim H and Kim SY: Gomisin N inhibits melanogenesis through
regulating the PI3K/Akt and MAPK/ERK signaling pathways in
melanocytes. Int J Mol Sci. 18:E4712017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ye D, Luo H, Lai Z, Zou L, Zhu L, Mao J,
Jacob T, Ye W, Wang L and Chen L: ClC-3 chloride channel proteins
regulate the cell cycle by up-regulating cyclin D1-CDK4/6 through
suppressing p21/p27 expression in nasopharyngeal carcinoma Cells.
Sci Rep. 6:302762016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hamid SM, Cicek S, Karamil S, Ozturk MB,
Debelec-Butuner B, Erbaykent-Tepedelen B, Varisli L, Gonen-Korkmaz
C, Yorukoglu K and Korkmaz KS: HOXB13 contributes to G1/S and G2/M
checkpoint controls in prostate. Mol Cell Endocrinol. 383:38–47.
2014. View Article : Google Scholar : PubMed/NCBI
|
